Streetbeat News

Stock Prices

DAL

LUV

UAL

Southwest Airlines (NYSE:LUV) stock is trading higher on Monday following reports that Elliott Investment Management is taking a $2 billion stake in the airline. Despite recent challenges, including technology failures and missed earnings estimates, the stock is up 8.11% premarket.

Portfolio Pulse from Anusuya Lahiri

June 10, 2024 | 12:29 pm

DO

NE

Diamond Offshore Drilling shares are trading higher after Noble announced an agreement to acquire the company.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 12:26 pm

SKYE

Skye Bioscience shares are trading lower after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve the target product profile and has discontinued the program.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 12:25 pm

CTSH

FCFY

QVAL

Cognizant Technology Solutions Corporation (NASDAQ: CTSH) has agreed to acquire Belcan, LLC for $1.3 billion in cash and stock. The acquisition aims to enhance Cognizant's ER&D capabilities and expand its market access. The deal is expected to close in Q3 2024, with significant revenue and cost synergies anticipated.

Portfolio Pulse from Lekha Gupta

June 10, 2024 | 12:24 pm

RY

Royal Bank of Canada (RY) has announced approval to repurchase up to 30 million common shares.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 12:22 pm

SIFY

Sify Technologies shares are trading lower after the company announced the voluntary delisting date of its ADS rights from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 12:22 pm

SKYE

Skye Bioscience announced that its Phase 2a trial of SBI-100 OE in glaucoma patients did not meet the primary endpoint. As a result, the company will discontinue related R&D and shift focus to its metabolic program, with a Phase 2 obesity trial for Nimacimab set to begin dosing in Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 12:21 pm

GM

MRK

NKE

XLE

On CNBC's 'Halftime Report Final Trades,' analysts recommended The Energy Select Sector SPDR Fund (XLE), General Motors (GM), Merck (MRK), and Nike (NKE). GM reported strong Q1 2024 results, Merck announced positive study results with Moderna, and Nike is reducing its workforce to save costs.

Portfolio Pulse from Avi Kapoor

June 10, 2024 | 12:14 pm

NVDA

Nvidia Corp. (NASDAQ:NVDA) is experiencing a decline in premarket trading, down 0.42% at $120.38. This follows a recent 10-for-1 stock split and a record high market cap of $3 trillion. The stock has pulled back in the last two sessions, and shares often see some weakness immediately after a split due to profit-taking.

Portfolio Pulse from Shanthi Rexaline

June 10, 2024 | 12:13 pm

HOTH

NVDA

Hoth Therapeutics has entered into a joint development agreement with Wise Systems International SRL to utilize Nvidia's BioNeMo AI platform for drug discovery. This collaboration aims to accelerate the training of models on proprietary data using generative AI.

Portfolio Pulse from Benzinga Newsdesk

June 10, 2024 | 12:13 pm